ISTH 2022 Congress
Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies » Acquired Thrombocytopenias
Theme Navigation
- ISTH 2022 Congress
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
- Acquired Thrombocytopenias
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
-
Abstract Number: VPB1220
A rare case of chronic immune thrombocytopenia with autoantibodies inhibiting platelet aggregation. Effects of romiplostim.
-
Abstract Number: VPB1221
A retrospective analysis of 45 cases of HIV-associated thrombocytopenia in a single center over ten years
-
Abstract Number: PB1196
Antioxidative capacity of platelets in the pathogenesis of immune thrombocytopenia; Finding the forest for trees
-
Abstract Number: VPB1217
Association of platelet desialylation and circulating follicular helper T cells in patients with thrombocytopenia
-
Abstract Number: VPB1224
Autoimmune mediated hematological disease associated with COVID-19 disease or vaccination: A multi-centre case series.
-
Abstract Number: PB1199
Changing treatment paradigm in second line treatment of adult ITP patients with the availability of TPO agonists: A retrospective study from a tertiary care center in India
-
Abstract Number: PB1205
Clinical and laboratory characteristics of adults with immune thrombocytopenia in a contemporary cohort in Austria
-
Abstract Number: PB1201
Clinical Characteristics and Maternal/Neonatal Outcomes in Pregnant Women with Immune Thrombocytopenic Purpura: A Systematic Review
-
Abstract Number: PB1208
Discontinuation of thrombopoietin receptor agonists: a 10 year real-world experience from an academic hospital in Madrid
-
Abstract Number: PB1197
Do Regulatory T cells Reemerge with Resolution of Childhood Immune Thrombocytopenia?
-
Abstract Number: PB1206
Effect of agonists to thrombopoietin receptors on platelet glycome of patients with immune thrombocytopenia
-
Abstract Number: PB1207
Effect Of Anti-Nuclear Antibody Positivity On Adult Newly Diagnosed Immune Thrombocytopenia Prognosis.
-
Abstract Number: PB1214
Effect of eltrombopag on platelet receptor expression and activation in patients with immune thrombocytopenia
-
Abstract Number: PB1215
Exacerbation of Immune Thrombocytopenia Following Initial and Booster Vaccination with Pfizer-BioNTech COVID-19 Vaccine
-
Abstract Number: PB1200
Factors Influencing Health-related Quality of Life in Patients with Immune Thrombocytopenia
-
Abstract Number: PB1203
Fostamatinib for the Treatment of Immune Thrombocytopenia in a Real-World Setting: A Case Series of Five Patients
-
Abstract Number: PB1209
Glycoprotein-specific Platelet Autoantibodies Predict Lower Platelet Counts in Thrombocytopenic Patients
-
Abstract Number: VPB1222
High Frequency of Bone Marrow Evaluations but Low Diagnostic Yield in Relapsed or Refractory Immune Thrombocytopenia
-
Abstract Number: PB1198
ITP before and after COVID-19 vaccinations: a national cohort study